Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 707(1-3): 78-86, 2013 May 05.
Article in English | MEDLINE | ID: mdl-23535605

ABSTRACT

In experimental cerebral ischemia, melanocortin MC4 receptor agonists induce neuroprotection and neurogenesis with subsequent long-lasting functional recovery. Here we investigated the molecular mechanisms underlying melanocortin-induced neurogenesis. Gerbils were subjected to transient global cerebral ischemia, then they were treated every 12 h, and until sacrifice, with 5-bromo-2'-deoxyuridine (BrdU; to label proliferating cells), and the melanocortin analog [Nle(4),d-Phe(7)]α-melanocyte-stimulating hormone (NDP-α-MSH) or saline. NDP-α-MSH increased hippocampus dentate gyrus (DG) expression of Wnt-3A, ß-catenin, Sonic hedgehog (Shh), Zif268, interleukin-10 (IL-10) and doublecortin (DCX), as detected at days 3, 6 and 10 after the ischemic insult. Further, an elevated number of BrdU immunoreactive cells was found at days 3 and 10, and an improved histological picture with reduced neuronal loss at day 10, associated with learning and memory recovery. Pharmacological blockade of the Wnt-3A/ß-catenin and Shh pathways, as well as of melanocortin MC4 receptors, prevented all effects of NDP-α-MSH. These data indicate that, in experimental brain ischemia, treatment with melanocortins acting at MC4 receptors induces neural stem/progenitor cell proliferation in the DG by promptly and effectively triggering the canonical Wnt-3A/ß-catenin and Shh signaling pathways. Activation of these pathways is associated with up-regulation of the repair factor Zif268 and the neurogenesis facilitating factor IL-10, and it seems to address mainly toward a neuronal fate, as indicated by the increase in DCX positive cells.


Subject(s)
Brain Ischemia/drug therapy , Receptor, Melanocortin, Type 4/agonists , Wnt Signaling Pathway/drug effects , alpha-MSH/analogs & derivatives , Animals , Brain Ischemia/pathology , Cell Proliferation/drug effects , Dentate Gyrus/drug effects , Dentate Gyrus/pathology , Disease Models, Animal , Doublecortin Domain Proteins , Gerbillinae , Hedgehog Proteins/metabolism , Male , Microtubule-Associated Proteins/metabolism , Neural Stem Cells/drug effects , Neural Stem Cells/metabolism , Neurogenesis/drug effects , Neurons/drug effects , Neurons/metabolism , Neuropeptides/metabolism , Signal Transduction/drug effects , Time Factors , Up-Regulation/drug effects , Wnt3A Protein/metabolism , alpha-MSH/pharmacology
2.
Acta Neuropathol ; 122(4): 443-53, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21927944

ABSTRACT

Melanocortins produce neuroprotection against ischemic stroke with subsequent long-lasting functional recovery, through melanocortin MC(4) receptor activation. Here we investigated whether the long-lasting beneficial effect of melanocortins in stroke conditions is associated with a stimulation of neurogenesis. Gerbils were subjected to transient global cerebral ischemia by occluding both common carotid arteries for 10 min; then, they were prepared for 5-bromo-2'-deoxyuridine (BrdU) labeling of proliferating cells. Delayed treatment (up to 9 h after the ischemic injury) for 11 days with the melanocortin analog [Nle(4),D-Phe(7)]α-melanocyte-stimulating hormone (NDP-α-MSH) improved learning and memory throughout the 50-day observation period. Immunohistochemical examination of the hippocampus on day 50 showed, in the dentate gyrus, an elevated number of BrdU immunoreactive cells colocalized with NeuN (used as indicator of mature neurons) and Zif268 (used as indicator of functionally integrated neurons). Retrospective analysis during the early stage of neural stem/progenitor cell development (days 3 and 4 after stroke) showed, in NDP-α-MSH-treated gerbils, a high degree of daily cell proliferation and revealed that NDP-α-MSH favorably affects Wnt-3A signaling pathways and doublecortin expression. Pharmacologic blockade of MC(4) receptors prevented all effects of NDP-α-MSH. These data indicate that treatment of cerebral ischemia with MC(4) receptor agonists induces, with a broad window of therapeutic opportunity, long-lasting functional recovery associated with a large number of mature and likely functional newborn neurons in brain injured areas. Our findings reveal previously undescribed effects of melanocortins which might have major clinical implications.


Subject(s)
Brain Ischemia/drug therapy , Brain Ischemia/metabolism , Melanocortins/physiology , Nerve Degeneration/drug therapy , Nerve Degeneration/metabolism , Neurogenesis/physiology , Receptor, Melanocortin, Type 4/metabolism , Recovery of Function/physiology , Animals , Brain Ischemia/pathology , Disease Models, Animal , Gerbillinae , Male , Melanocortins/pharmacology , Nerve Degeneration/pathology , Receptor, Melanocortin, Type 4/physiology , Recovery of Function/drug effects , Time Factors
3.
J Neuropathol Exp Neurol ; 67(7): 687-701, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18596544

ABSTRACT

In limbic seizures, neuronal excitation is conveyed from the entorhinal cortex directly to CA1 and subicular regions. This phenomenon is associated with a reduced ability of CA3 to respond to entorhinal cortex inputs. Here, we describe a lesion that destroys the perforant path in CA3 after status epilepticus (SE) induced by pilocarpine injection in 8-week-old rats. Using magnetic resonance imaging, immunohistochemical, and ultrastructural analyses, we determined that this lesion develops after 30 minutes of SE and is characterized by microhemorrhages and ischemia. After a longer period of SE, the lesion invariably involves the upper blade of the dentate gyrus. Adult rats treated with subcutaneous diazepam (20 mg kg for 3 days) did not develop the dentate gyrus lesion and had less frequent spontaneous recurrent seizures (p < 0.01). Young (3-week-old) rats rarely (20%) developed the CA3 lesion, and their spontaneous seizures were delayed (p < 0.01). To investigate the role of the damaged CA3 in seizure activity, we reinduced SE in adult and young epileptic rats. Using FosB/DeltaFosB markers, we found induction of FosB/DeltaFosB immunopositivity in CA3 neurons of young but not in adult rats. These experiments indicate that SE can produce a focal lesion in the perforant path that may affect the roles of the hippocampus in epileptic rats.


Subject(s)
Brain Injuries/pathology , Entorhinal Cortex/pathology , Hippocampus/pathology , Status Epilepticus/pathology , Age Factors , Animals , Animals, Newborn , Anticonvulsants/therapeutic use , Brain Injuries/chemically induced , Brain Injuries/complications , Brain Injuries/drug therapy , Diazepam/therapeutic use , Disease Models, Animal , Entorhinal Cortex/drug effects , Entorhinal Cortex/ultrastructure , Gene Expression Regulation/drug effects , Guanine Nucleotide Exchange Factors , Heme Oxygenase-1/metabolism , Hippocampus/drug effects , Hippocampus/ultrastructure , Laminin/metabolism , Magnetic Resonance Imaging/methods , Male , Microscopy, Electron, Transmission/methods , Nerve Tissue Proteins/metabolism , Neural Pathways/pathology , Neural Pathways/ultrastructure , Pilocarpine , Proto-Oncogene Proteins , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Sprague-Dawley , Rho Guanine Nucleotide Exchange Factors , Status Epilepticus/chemically induced , Status Epilepticus/complications , Status Epilepticus/drug therapy , Status Epilepticus/prevention & control
5.
Exp Neurol ; 187(2): 350-8, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15144861

ABSTRACT

The inducible isoform of nitric oxide synthase (iNOS), produces nitric oxide (NO) from l-arginine in response to inflammatory stimuli. NO sub-serves different functions from cytotoxicity to neuroprotection and triggers either necrosis or apoptosis. This study shows by Northern blot analysis that during experimental allergic neuritis (EAN), at the beginning of clinical signs, there is a transient extensive iNOS mRNA induction in nerve roots, in which morphology is mainly characterized by severe demyelination, but not in sciatic nerve, where scattered axonal degeneration is evident. Immunocytochemistry performed on teased nerve fibers and ultrastructural analysis showed that iNOS was localized in both inflammatory and Schwann cells, and the study of cell membrane permeability detected with fluorescent dyes showed a diffuse necrotic phenotype in the whole peripheral nervous system (PNS). With EAN clinical progression toward spontaneous recovery, endoneurial iNOS was rapidly down-regulated and in nerve roots almost all cells shifted their membrane permeability to an apoptotic phenotype, while necrosis persisted in sciatic nerve, until complete clinical recovery, when both root and nerve returned to normal. During wallerian degeneration following sciatic nerve transection, iNOS was undetectable in PNS, while endoneurial cell membrane had a diffuse necrotic phenotype. These data support the hypothesis that, during cell-mediated demyelination, iNOS may influence Schwann cell-axon relationship causing axonal damage and regulating endoneurial cell life and death.


Subject(s)
Demyelinating Diseases/enzymology , Neuritis, Autoimmune, Experimental/enzymology , Nitric Oxide Synthase/metabolism , Peripheral Nervous System/enzymology , Wallerian Degeneration/enzymology , Animals , Blotting, Northern , Cell Membrane Permeability/physiology , Demyelinating Diseases/immunology , Demyelinating Diseases/pathology , Disease Models, Animal , Disease Progression , Enzyme Induction/physiology , Immunohistochemistry , Nerve Fibers/enzymology , Nerve Fibers/pathology , Neuritis, Autoimmune, Experimental/immunology , Neuritis, Autoimmune, Experimental/pathology , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Peripheral Nervous System/pathology , Rats , Rats, Inbred Lew , Sciatic Nerve/enzymology , Sciatic Nerve/pathology , Wallerian Degeneration/pathology
6.
Anat Embryol (Berl) ; 206(1-2): 21-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12478364

ABSTRACT

The onset and development of intramembranous ossification centers in the cranial vault and around the shaft of long bones in five newborn rabbits and six chick embryos were studied by light (LM) and transmission electron microscopy (TEM). Two subsequent different types of bone formation were observed. We respectively named them static and dynamic osteogenesis, because the former is characterized by pluristratified cords of unexpectedly stationary osteoblasts, which differentiate at a fairly constant distance (28+/-0.4 microm) from the blood capillaries, and the latter by the well-known typical monostratified laminae of movable osteoblasts. No significant structural and ultrastructural differences were found between stationary and movable osteoblasts, all being polarized secretory cells joined by gap junctions. However, unlike in typical movable osteoblastic laminae, stationary osteoblasts inside the cords are irregularly arranged, variously polarized and transform into osteocytes, clustered within confluent lacunae, in the same place where they differentiate. Static osteogenesis is devoted to the building of the first trabecular bony framework having, with respect to the subsequent bone apposition by typical movable osteoblasts, the same supporting function as calcified trabeculae in endochondral ossification. In conclusion, it appears that while static osteogenesis increases the bone external size, dynamic osteogenesis is mainly involved in bone compaction, i.e., in filling primary haversian spaces with primary osteons.


Subject(s)
Osteogenesis/physiology , Skull/growth & development , Tibia/embryology , Tibia/growth & development , Animals , Animals, Newborn , Cell Differentiation , Chick Embryo , Microscopy, Electron, Scanning , Osteocytes/physiology , Osteocytes/ultrastructure , Rabbits , Skull/embryology , Skull/ultrastructure , Tibia/ultrastructure
7.
J Cardiovasc Pharmacol ; 40(3): 388-98, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12198325

ABSTRACT

Combined treatment with the angiotensin-converting enzyme (ACE) inhibitor delapril and the diuretic indapamide prevented vascular damage in vital organs of salt-loaded stroke-prone spontaneously hypertensive rats (SHRsp). Whether the changes occurring after long-term hypertension could also be modulated in large arteries was investigated. Two-month-old SHRsp were salt loaded and treated with the drug regimen until they reached 50% mortality or around midlife. In a first experiment, delapril (12 mg/kg) and indapamide (1 mg/kg) were administered daily separately or in combination. In the second dose-finding experiment, delapril (6, 3, 1.5 mg/kg) and indapamide (0.5, 0.25, 0.125 mg/kg) in decreasing dose combinations were analyzed. Ultrastructural, histomorphometric, and biochemical studies were performed on the thoracic aorta. When compared with delapril (12 mg/kg) or indapamide (1 mg/kg) administered individually for 5 months, the combination 12 + 1 mg/kg was able to prevent the increase in extracellular matrix deposition observed in other treatment groups, as assessed by histomorphometry or 4-OH-proline biochemical determination. In the second experiment, a half-dose (delapril 6 mg/kg + indapamide 0.5 mg/kg) combination was similarly effective in counteracting fibrosis, but the other doses progressively failed. In the first experiment, the combination had a stabilizing effect on hypertension and stimulated diuresis. In the second experiment, arterial blood pressure values and sodium balance were not consistently affected by the treatments that antagonized fibrosis (i.e., delapril 6 mg/kg + indapamide 0.5 mg/kg and, less efficiently, delapril 3 mg/kg + indapamide 0.25 mg/kg). These results suggest that indapamide interacts with ACE inhibitors to limit aortic fibrosis independent of any well-established mechanism.


Subject(s)
Aorta, Thoracic/drug effects , Aorta, Thoracic/pathology , Hypertension/prevention & control , Indans/administration & dosage , Indapamide/administration & dosage , Stroke/drug therapy , Animals , Dose-Response Relationship, Drug , Drug Synergism , Drug Therapy, Combination , Fibrosis , Hypertension/pathology , Male , Rats , Rats, Inbred SHR , Stroke/pathology
8.
J Bioenerg Biomembr ; 34(1): 67-79, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11860182

ABSTRACT

Hepatic fibrosis due to iron overload is mediated by oxidant stress. The basic mechanisms underlying this process in vivo are still little understood. Acutely iron-dosed gerbils were assayed for lobular accumulation of hepatic lipid peroxidation by-products, oxidant-stress gene response, mitochondrial energy-dependent functions, and fibrogenesis. Iron overload in nonparenchymal cells caused an activation of hepatic stellate cells and fibrogenesis. Oxidant-stress gene response and accumulation of malondialdehyde-protein adducts were restricted to iron-filled nonparenchymal cells, sparing nearby hepatocytes. Concomitantly, a significant rise in the mitochondrial desferrioxamine-chelatable iron pool associated with the impairment of mitochondrial oxidative metabolism and the hepatic ATP decrease, was detected. Ultrastructural mitochondrial alterations were observed only in nonparenchymal cells. All biochemical and functional derangements were hindered by in vivo silybin administration which blocked completely fibrogenesis. Iron-induced oxidant stress in nonparenchymal cells appeared to bring about irreversible mitochondrial derangement associated with the onset of hepatic fibrosis.


Subject(s)
Hepatocytes/metabolism , Iron/toxicity , Oxidative Stress/drug effects , Adenosine Triphosphate/biosynthesis , Animals , Chemical and Drug Induced Liver Injury , Electron Transport , Electron Transport Complex IV/metabolism , Fibrosis/chemically induced , Fibrosis/pathology , Fibrosis/prevention & control , Gerbillinae , Hepatocytes/drug effects , Hepatocytes/pathology , Iron/administration & dosage , Iron Overload/complications , Iron Overload/pathology , Liver Diseases/pathology , Liver Diseases/prevention & control , Male , Membrane Potentials , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , Mitochondria, Liver/pathology , Mitochondrial Diseases/chemically induced , Mitochondrial Diseases/prevention & control , Oxidative Stress/physiology , Silymarin/pharmacology , Silymarin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...